Medifast (MED) Tops Q2 EPS by 11c

Medifast (NYSE: MED) reported Q2 EPS of $0.63, $0.11 better than the analyst estimate of $0.52. Revenue for the quarter came in at $75.7 million versus the consensus estimate of $71.96 million.

For earnings history and earnings-related data on Medifast (MED) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Silexion Therapeutics (SLXN) Tops Q2 EPS by 793c
• CaliberCos Inc (CWD) Misses Q2 EPS by 43c; Offers Guidance